(MedPage Today) -- The novel type 2 diabetes drug canagliflozin (Invocana) is effective at lowering blood glucose, but FDA reviewers have raised concerns about renal and fracture risks. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment